Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
293
datasets available to search
ShareScore release 0.9.0
Dataset results
293 results for “PARP”
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04149145. IPD Sharing: NO. Countries: 0. Publications: 1.
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
ClinicalTrials.gov study NCT04034927. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
ClinicalTrials.gov study NCT01286987. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study
ClinicalTrials.gov study NCT04197713. IPD Sharing: YES. Countries: 1. Publications: 0.
The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
ClinicalTrials.gov study NCT06242392. IPD Sharing: NO. Countries: 0. Publications: 6.
Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT01127178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors
ClinicalTrials.gov study NCT01311713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PARP Inhibition for Gliomas (PI-4G or π4g)
ClinicalTrials.gov study NCT05297864. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
ClinicalTrials.gov study NCT03787680. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05501548. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04837209. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT01085422. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
ClinicalTrials.gov study NCT03990896. IPD Sharing: YES. Countries: 1. Publications: 0.
Deletion of 11q in neuroblastomas drives sensitivity to PARP inhibition
GEO Series GSE101990. Homo sapiens. 48 samples. Type: Genome variation profiling by SNP array; Genome variation profiling by high throughput sequencing.
Sequential Platinum and PARP Inhibition Enhances PD1 Immunotherapy Efficacy in Murine Brca2 Mutated Pancreatic Cancer [RNAseq_2]
GEO Series GSE300888. Mus musculus. 14 samples. Type: Expression profiling by high throughput sequencing.
Immunogenicity of BRCA1-deficient Ovarian Cancers is Driven through DNA Sensing and is Augmented by PARP Inhibition
GEO Series GSE122155. Homo sapiens. 12 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Other.
PARP-1, H3 and H3K4me3 ChIP-chip from MCF7 cells
GEO Series GSE19619. Homo sapiens. 6 samples. Type: Genome binding/occupancy profiling by genome tiling array.
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA Associated Pancreatic Cancer in the Clinical and Pre-clinical Setting
GEO Series GSE235843. Homo sapiens. 69 samples. Type: Expression profiling by high throughput sequencing.
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP-inhibition [RNA-seq]
GEO Series GSE288569. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Integration of Thermal Proteome Profiling with phosphoproteomic and transcriptomic data via mechanistic network models decodes the molecular response to PARP inhibition
GEO Series GSE243208. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.